Remetinostat
- Generic Name
- Remetinostat
- Drug Type
- Small Molecule
- Chemical Formula
- C16H21NO6
- CAS Number
- 946150-57-8
- Unique Ingredient Identifier
- 37NT056AT4
Overview
Remetinostat is under investigation in clinical trial NCT02213861 (Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma).
Background
Remetinostat is under investigation in clinical trial NCT02213861 (Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2019/03/15 | Phase 2 | Terminated | Kavita Sarin | ||
2017/06/08 | Phase 2 | Completed | Kavita Sarin | ||
2015/12/21 | Phase 2 | UNKNOWN | TetraLogic Pharmaceuticals | ||
2014/08/12 | Phase 2 | UNKNOWN | TetraLogic Pharmaceuticals | ||
2012/07/20 | Phase 1 | Completed | TetraLogic Pharmaceuticals |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
Singapore Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. | Online |
|---|
No Singapore products found
No Singapore products found for this drug
China Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|
No China products found
No China products found for this drug
Australia Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No Australia products found
No Australia products found for this drug
© Copyright 2025. All Rights Reserved by MedPath